192 related articles for article (PubMed ID: 36207693)
21. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
Olsen JR; Dehdashti F; Siegel BA; Zighelboim I; Grigsby PW; Schwarz JK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):772-7. PubMed ID: 20888130
[TBL] [Abstract][Full Text] [Related]
22. Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence.
Salvatici M; Achilarre MT; Sandri MT; Boveri S; Vanna Z; Landoni F
Gynecol Oncol; 2016 Jul; 142(1):115-119. PubMed ID: 27117922
[TBL] [Abstract][Full Text] [Related]
23. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
[TBL] [Abstract][Full Text] [Related]
24. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631
[TBL] [Abstract][Full Text] [Related]
26. Serum miR-638 Combined with Squamous Cell Carcinoma-Related Antigen as Potential Screening Biomarkers for Cervical Squamous Cell Carcinoma.
Zheng S; Li R; Liang J; Wen Z; Huang X; Du X; Dong S; Zhu K; Chen X; Liu D; Wu J; Liu Y; Zou X; Wang Y; Li J; Zeng F; Feng L; Yang G; Jing C
Genet Test Mol Biomarkers; 2020 Apr; 24(4):188-194. PubMed ID: 32216635
[No Abstract] [Full Text] [Related]
27. The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis.
Charakorn C; Thadanipon K; Chaijindaratana S; Rattanasiri S; Numthavaj P; Thakkinstian A
Gynecol Oncol; 2018 Jul; 150(1):190-200. PubMed ID: 29606483
[TBL] [Abstract][Full Text] [Related]
28. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
Choi KH; Lee SW; Yu M; Jeong S; Lee JW; Lee JH
J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
[TBL] [Abstract][Full Text] [Related]
29. Laparoscopic surgery for early cervical squamous cell carcinoma and its effect on the micrometastasis of cancer cells.
Wei XQ; Ma Y; Chen Y; Liu X; Zhao M; Zhou LW
Medicine (Baltimore); 2018 Aug; 97(34):e11921. PubMed ID: 30142804
[TBL] [Abstract][Full Text] [Related]
30. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
Davelaar EM; van de Lande J; von Mensdorff-Pouilly S; Blankenstein MA; Verheijen RH; Kenemans P
Tumour Biol; 2008; 29(1):9-17. PubMed ID: 18497544
[TBL] [Abstract][Full Text] [Related]
31. Integrated pretreatment diffusion kurtosis imaging and serum squamous cell carcinoma antigen levels: a biomarker strategy for early assessment of radiotherapy outcomes in cervical cancer.
Zheng X; Shen F; Chen W; Ren W; Tang S
Abdom Radiol (NY); 2024 May; 49(5):1502-1511. PubMed ID: 38536425
[TBL] [Abstract][Full Text] [Related]
32. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
van de Lande J; Davelaar EM; von Mensdorff-Pouilly S; Water TJ; Berkhof J; van Baal WM; Kenemans P; Verheijen RH
Gynecol Oncol; 2009 Jan; 112(1):119-25. PubMed ID: 19007978
[TBL] [Abstract][Full Text] [Related]
33. The Level of Squamous Cell Carcinoma Antigen and Lymph Node Metastasis in Locally Advanced Cervical Cancer.
Lekskul N; Charakorn C; Lertkhachonsuk AA; Rattanasiri S; Israngura Na Ayudhya N
Asian Pac J Cancer Prev; 2015; 16(11):4719-22. PubMed ID: 26107230
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
Huang EY; Huang YJ; Chanchien CC; Lin H; Wang CJ; Sun LM; Tseng CW; Tsai CC; Ou YC; Fu HC; Chen HC; Hsu HC; Wang CY
Radiat Oncol; 2012 Jan; 7():13. PubMed ID: 22289572
[TBL] [Abstract][Full Text] [Related]
35. Application of tumor markers SCC-Ag, CEA, and TPA in patients with cervical precancerous lesions.
Farzaneh F; Shahghassempour S; Noshine B; Arab M; Yaseri M; Rafizadeh M; Alizadeh K
Asian Pac J Cancer Prev; 2014; 15(9):3911-4. PubMed ID: 24935573
[TBL] [Abstract][Full Text] [Related]
36. The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer.
Fu J; Wang W; Wang Y; Liu C; Wang P
Radiat Oncol; 2019 Aug; 14(1):146. PubMed ID: 31416463
[TBL] [Abstract][Full Text] [Related]
37. Serum expression level of squamous cell carcinoma antigen, highly sensitive C-reactive protein, and CA-125 as potential biomarkers for recurrence of cervical cancer.
Guo S; Yang B; Liu H; Li Y; Li S; Ma L; Liu J; Guo W
J Cancer Res Ther; 2017; 13(4):689-692. PubMed ID: 28901315
[TBL] [Abstract][Full Text] [Related]
38. Association of pretreatment SUV
Shou H; Yasuo Y; Yuan S; Lou H; Ni J
Int J Gynaecol Obstet; 2021 Jan; 152(1):112-117. PubMed ID: 33141954
[TBL] [Abstract][Full Text] [Related]
39. Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
Guo HT; Bi XH; Lei T; Lv X; Yao G; Chen Y; Liu C
BMC Cancer; 2020 May; 20(1):441. PubMed ID: 32429859
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Value of Serum N1-Methylnicotinamide in Cervical Cancer Patients.
Ji M; Na N; Lin S
Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
